DEUTSCHE BANK AG\ - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 37 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q4 2019$0
-100.0%
2,686
-83.1%
0.00%
Q3 2019$5,000
+150.0%
15,940
+64.9%
0.00%
Q2 2019$2,000
-88.2%
9,669
-81.7%
0.00%
Q1 2019$17,000
-73.4%
52,896
-0.7%
0.00%
Q4 2018$64,000
-80.4%
53,276
-69.7%
0.00%
Q3 2018$327,000
+5.5%
175,568
+26.7%
0.00%
Q2 2018$310,000
+425.4%
138,606
+411.9%
0.00%
Q1 2018$59,00027,0790.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q2 2018
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,079,080$27,178,0000.29%
jvl associates llc 58,500$132,0000.13%
Sigma Planning Corp 27,500$62,0000.00%
NORTHWEST WEALTH MANAGEMENT, LLC 280$1,0000.00%
Tower Research Capital LLC (TRC) 4,158$9,0000.00%
Ameritas Investment Partners, Inc. 2,890$7,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 60,388$136,0000.00%
UBS Group AG 9,495$21,0000.00%
RHUMBLINE ADVISERS 31,685$71,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1,290$2,902,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders